---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-000012"
form_type: "8-K"
ticker: "IMCR"
cik: "0001671927"
company_name: "Immunocore Holdings plc"
filed_at: "2024-01-02T23:59:59+00:00"
generated_at: "2026-06-07T05:20:28.063710+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Immunocore transitions to U.S. domestic issuer effective January 1, 2024

## Summary
- Will file periodic reports on U.S. domestic issuer forms, which are more detailed and require faster filing.
- Previously qualified as a foreign private issuer prior to January 1, 2024.
- Company lists disclosure channels: SEC filings, press releases, website, LinkedIn, and X account.

## SEC filing metadata
- accession: 0001140361-24-000012
- form_type: 8-K
- ticker: IMCR
- cik: 0001671927
- company_name: Immunocore Holdings plc
- filed_at: 2024-01-02T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671927/000114036124000012/0001140361-24-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671927/000114036124000012/ef20017537_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-000012
- JSON: https://secwatch.observer/filing/0001140361-24-000012.json
- Plain text: https://secwatch.observer/filing/0001140361-24-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.